(VIANEWS) - Conifer Holdings (CNFR), Build (BBW), Pan American Silver Corp. (PAAS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Conifer Holdings (CNFR)
21.1% sales growth and 10.85% return on equity
Conifer Holdings, Inc., an insurance holding company, engages in the sale of property and casualty insurance products.
Conifer Holdings's sales growth this year is expected to be 20.6% and 11.8% for next year.
Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 109.45M for the twelve trailing months.
Volume
Today's last reported volume for Conifer Holdings is 8295 which is 95.26% below its average volume of 175103.
Conifer Holdings's sales growth is a negative 0% for the present quarter and 21.1% for the next. The company's growth estimates for the present quarter and the next is 58.3% and 80.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.85%.
Volatility
Conifer Holdings's last day, last week, and last month's current volatility was 1.09%, 1.44%, and 1.56%, respectively.
Conifer Holdings's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.56% (day), 2.83% (last week), and 4.65% (last month), respectively.
Conifer Holdings's Stock Yearly Top and Bottom Value
Conifer Holdings's stock is valued at $2.76 at 10:22 EST, way below its 52-week high of $5.00 and way higher than its 52-week low of $2.16.
Conifer Holdings's Moving Average
Conifer Holdings's value is above its 50-day moving average of $2.71 and below its 200-day moving average of $2.91.2. Build (BBW)
19.5% sales growth and 42.02% return on equity
Build-A-Bear Workshop, Inc. operates as a specialty retailer of plush animals and related products.
Build's sales growth this year is expected to be 50% and 6.8% for next year.
Year-on-year quarterly revenue growth grew by 134.7%, now sitting on 354.75M for the twelve trailing months.
Volume
Today's last reported volume for Build is 100866 which is 44.61% below its average volume of 182120.
Build's sales growth is a negative 0% for the current quarter and 19.5% for the next. The company's growth estimates for the current quarter and the next is a negative 254.5% and 61.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.02%.
Volatility
Build's last day, last week, and last month's current volatility was 3.42%, 1.50%, and 1.95%, respectively.
Build's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.82% (day), 4.12% (last week), and 4.47% (last month), respectively.
Build's Stock Yearly Top and Bottom Value
Build's stock is valued at $16.62 at 10:22 EST, way under its 52-week high of $21.00 and way higher than its 52-week low of $3.71.
Build's Moving Average
Build's value is higher than its 50-day moving average of $16.47 and higher than its 200-day moving average of $15.17.Previous days news about Build(BBW)
- House rule vote sets stage for action on ‘build back better’ bill by midmonth. According to MarketWatch on Saturday, 6 November, "In a two-sentence statement, five moderates said that if the fiscal estimates raise problems, "we remain committed to working to resolve any discrepancies in order to pass the Build Back Better legislation." The five included Rep. Josh Gottheimer of New Jersey, leader of a group of centrists who this summer repeatedly pressured House Speaker Nancy Pelosi of California to schedule earlier votes on the infrastructure bill.", "The Build Back Better Act, he said, according to the statement, represents "a once-in-a-generation investment in our people" that "will lower bills for healthcare, child care, elder care, prescription drugs, and preschool. "
- According to The New York Times on Saturday, 6 November, "The prospect of trillions of dollars of new federal funding for infrastructure projects under Mr. Biden's Build Back Better program is raising hopes that roads, bridges, railways, wind farms, electric grids and water mains could provide millions of good construction jobs for a generation or more."
- According to Bloomberg Quint on Saturday, 6 November, "I am urging all members to vote for both the rule for consideration of the Build Back Better Act and final passage of the Bipartisan Infrastructure bill tonight," Biden said in a brief statement.", "I am confident that during the week of Nov. 15, the House will pass the Build Back Better Act."
3. Pan American Silver Corp. (PAAS)
14.2% sales growth and 11.84% return on equity
Pan American Silver Corp., together with its subsidiaries, engages in the exploration, development, extraction, processing, refining, and reclamation of silver, gold, zinc, lead, and copper mines in Canada, Mexico, Peru, Argentina, and Bolivia.
Pan American Silver Corp.'s sales growth this year is anticipated to be 29.4% and 22.1% for next year.
Year-on-year quarterly revenue growth grew by 53.2%, now sitting on 1.48B for the twelve trailing months.
Volume
Today's last reported volume for Pan American Silver Corp. is 1635770 which is 9.19% below its average volume of 1801500.
Pan American Silver Corp.'s sales growth for the next quarter is 14.2%. The company's growth estimates for the current quarter and the next is 11.8% and negative -24.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.84%.
Volatility
Pan American Silver Corp.'s last day, last week, and last month's current volatility was 3.42%, 1.79%, and 1.62%, respectively.
Pan American Silver Corp.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.50% (day), 3.65% (last week), and 2.85% (last month), respectively.
Pan American Silver Corp.'s Stock Yearly Top and Bottom Value
Pan American Silver Corp.'s stock is valued at $25.99 at 10:22 EST, way under its 52-week high of $39.62 and way higher than its 52-week low of $22.27.
Pan American Silver Corp.'s Moving Average
Pan American Silver Corp.'s worth is higher than its 50-day moving average of $24.72 and under its 200-day moving average of $28.08.4. First Bancorp (FBNC)
13.7% sales growth and 12.01% return on equity
First Bancorp operates as the bank holding company for First Bank that provides banking products and services for individuals and small to medium-sized businesses primarily in North Carolina and northeastern South Carolina.
First Bancorp's sales growth this year is anticipated to be 6.1% and 15.5% for next year.
Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 301.54M for the twelve trailing months.
Volume
Today's last reported volume for First Bancorp is 15478 which is 92.74% below its average volume of 213249.
First Bancorp's sales growth is a negative 0% for the current quarter and 13.7% for the next. The company's growth estimates for the current quarter and the next is 13.6% and negative -45.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.01%.
Volatility
First Bancorp's last day, last week, and last month's current volatility was 0.67%, 1.19%, and 1.55%, respectively.
First Bancorp's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.85% (day), 2.47% (last week), and 3.02% (last month), respectively.
First Bancorp's Stock Yearly Top and Bottom Value
First Bancorp's stock is valued at $50.39 at 10:22 EST, under its 52-week high of $50.47 and way above its 52-week low of $30.25.
First Bancorp's Moving Average
First Bancorp's value is above its 50-day moving average of $46.68 and way above its 200-day moving average of $43.00.5. Mercer International (MERC)
12.7% sales growth and 14.17% return on equity
Mercer International Inc., together with its subsidiaries, manufactures and sells northern bleached softwood kraft (NBSK) pulp in Europe, the United States, Asia, and internationally.
Mercer International's sales growth this year is anticipated to be 24.6% and 3.9% for next year.
Year-on-year quarterly revenue growth grew by 41%, now sitting on 1.68B for the twelve trailing months.
Volume
Today's last reported volume for Mercer International is 363847 which is 19.62% above its average volume of 304153.
Mercer International's sales growth for the next quarter is 12.7%. The company's growth estimates for the ongoing quarter and the next is 590.9% and 450%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.17%.
Volatility
Mercer International's last day, last week, and last month's current volatility was 0.19%, 1.01%, and 1.94%, respectively.
Mercer International's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.38% (day), 5.47% (last week), and 5.02% (last month), respectively.
Mercer International's Stock Yearly Top and Bottom Value
Mercer International's stock is valued at $10.40 at 10:22 EST, way below its 52-week high of $18.14 and way above its 52-week low of $6.91.
Mercer International's Moving Average
Mercer International's worth is below its 50-day moving average of $11.08 and way under its 200-day moving average of $12.55.6. Innospec (IOSP)
10.8% sales growth and 9.57% return on equity
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally.
Innospec's sales growth this year is anticipated to be 17.8% and 10.4% for next year.
Year-on-year quarterly revenue growth grew by 41.9%, now sitting on 1.38B for the twelve trailing months.
Volume
Today's last reported volume for Innospec is 69641 which is 28.69% below its average volume of 97666.
Innospec's sales growth for the next quarter is 10.8%. The company's growth estimates for the ongoing quarter and the next is a negative 18.9% and 26.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.57%.
Volatility
Innospec's last day, last week, and last month's current volatility was 3.89%, 2.05%, and 1.20%, respectively.
Innospec's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.83% (day), 4.09% (last week), and 2.65% (last month), respectively.
Innospec's Stock Yearly Top and Bottom Value
Innospec's stock is valued at $93.92 at 10:22 EST, way below its 52-week high of $107.73 and way above its 52-week low of $72.88.
Innospec's Moving Average
Innospec's worth is above its 50-day moving average of $86.78 and higher than its 200-day moving average of $92.15.7. United Therapeutics Corporation (UTHR)
10.5% sales growth and 13.99% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
United Therapeutics Corporation's sales growth this year is anticipated to be 12.9% and 10.3% for next year.
Year-on-year quarterly revenue growth grew by 23.3%, now sitting on 1.59B for the twelve trailing months.
Volume
Today's last reported volume for United Therapeutics Corporation is 407320 which is 7.96% above its average volume of 377281.
United Therapeutics Corporation's sales growth for the next quarter is 10.5%. The company's growth estimates for the current quarter and the next is a negative 7.3% and 63.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.99%.
Volatility
United Therapeutics Corporation's last day, last week, and last month's current volatility was 0.43%, 1.88%, and 1.40%, respectively.
United Therapeutics Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.10% (day), 4.02% (last week), and 2.85% (last month), respectively.
United Therapeutics Corporation's Stock Yearly Top and Bottom Value
United Therapeutics Corporation's stock is valued at $202.30 at 10:22 EST, under its 52-week high of $216.90 and way above its 52-week low of $129.43.